Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 701–800 of 1,001
Chen, Y., Ren, Q., Zhou, Z., Deng, L., Hu, L., Zhang, L., & Li, Z. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14980 · Cited by 33
“The free fatty acid receptor 1 (FFAR1, also known as GPR40) is a GPCR mainly expressed in pancreatic β-cells, which plays an important role in the glucose-stimulated insulin secretion (Briscoe et al., 2003; Itoh et al., 2003).”
BackgroundManosalva, C., Alarcón, P., González, K., Soto, J., Igor, K., Peña, F., Medina, G. A., Burgos, R. A., & Hidalgo, M. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00595 · Cited by 32
Simard, J.-C., Thibodeau, J.-F., Leduc, M., Tremblay, M., Laverdure, A., Sarra‐Bournet, F., Gagnon, W., Ouboudinar, J., Gervais, L., Felton, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69675-8 · Cited by 40
Druggable Lipid GPCRs: Past, Present, and Prospects
Mizuno, H., & Kihara, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50621-6_10 · Cited by 34
de Souza, J., Prom, C., & Lock, A. L. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-19312 · Cited by 33
Nishizaki, H., Matsuoka, O., Kagawa, T., Kobayashi, A., Watanabe, M., & Moritoh, Y. (2021) · Diabetes · doi:10.2337/db21-0451 · Cited by 36
Liver-derived metabolites as signaling molecules in fatty liver disease
Keles, U., Ow, J. R., Kuentzel, K. B., Zhao, L. N., & Kaldis, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04658-8 · Cited by 41
Darling, R. A., Zhao, H., Kinch, D. C., Li, A., Simasko, S. M., & Ritter, S. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00536.2013 · Cited by 37
“GPR40 (7, 28) and GPR120 (20, 28, 53) respond to both medium- and long-chain FAs, as well as saturated FAs, and have been reported in pancreatic islets, intestinal enteroendocrine cells (19), taste cells (10), and brain (4, 47, 48).”
BackgroundInfluentialKita, T., Kadochi, Y., Takahashi, K., Fukushima, K., Yamasaki, E., Uemoto, T., Hirane, M., Fukushima, N., Honoki, K., & Tsujiuchi, T. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.008 · Cited by 33
Gustatory Mechanisms for Fat Detection
Gilbertson, T. A., Yu, T., & Shah, B. P. (2009) · Frontiers in neuroscience · doi:10.1201/9781420067767-c3 · Cited by 37
Matsumoto, K., Yoshitomi, T., Ishimoto, Y., Tanaka, N., Takahashi, K., Watanabe, A., & Chiba, K. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250019 · Cited by 32
“GPR119 recognizes 2-monoacylglycerol as the endogenous ligands, whereas GPR40 recognizes medium or long-chain fatty acid (Itoh et al., 2003; Hansen et al., 2011; Ekberg et al., 2016).”
BackgroundThe role of orphan G protein-coupled receptors in the modulation of pain: A review
Nourbakhsh, F., Atabaki, R., & Roohbakhsh, A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.028 · Cited by 37
Ow, J. R., Caldez, M. J., Zafer, G., Foo, J. C., Li, H. Y., Ghosh, S., Wollmann, H., Cazenave‐Gassiot, A., Ong, C. B., Wenk, M. R., et al. (2020) · eLife · doi:10.7554/elife.63835 · Cited by 31
Aizenshtadt, A., Wang, C., Abadpour, S., Menezes, P. D., Wilhelmsen, I., Dalmao‐Fernández, A., Stokowiec, J., Golovin, A., Johnsen, M., Combriat, T. M. D., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303785 · Cited by 39
Mechanisms Mediating the Actions of Fatty Acids in the Hypothalamus
Dragano, N. R. V., Monfort‐Pires, M., & Velloso, L. A. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.012 · Cited by 34
Zhu, S., Zhang, J., Jiang, X. J., Wang, W., & Chen, Y. Q. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104060 · Cited by 33
“11,12 FFAR1 is mainly expressed in pancreatic b cells 13 and may ameliorate intestinal inflammation through an indirect mechanism.”
Zhang, Z., Sun, L., Chen, R., Lai, X., Lai, X., Wen, S., Cao, J., Lai, Z., Li, Z., & Sun, S. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.137223 · Cited by 32
Sequence Polymorphisms Provide a Common Consensus Sequence for GPR41 and GPR42
Liaw, C. W., & Connolly, D. T. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0916 · Cited by 35
“GPR40 was found to be activated by medium and long chain fatty acids (Briscoe et al. , 2003; Itoh et al. , 2003; Kotarsky et al. , 2003), whereas GPR41 and GPR43 were activated by short chain fatty acids (Brown et al. , 2003; Le Poul et al. , 2003; Nilsson et al. , 2003).”
InfluentialZhao, Y.-F., Pei, J., & Chen, C. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0105 · Cited by 35
“The GPR40 signalling pathway is a newly discovered pathway for FFAs in mediating b-cell function (Briscoe et al. 2003, Itoh et al. 2003).”
BackgroundHidalgo‐Figueroa, S., Navarrete‐Vázquez, G., Estrada-Soto, S. E., Giles-Rivas, D., Alarcón-Aguilar, F. J., León‐Rivera, I., Giacoman‐Martínez, A., Miranda-Pérez, E., & Almanza-Pérez, J. C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.033 · Cited by 30
Sankoda, A., Harada, N., Kato, T., Ikeguchi, E., Iwasaki, K., Yamane, S., Murata, Y., Hirasawa, A., & Inagaki, N. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13059 · Cited by 31
Zhou, Y., Sun, P. G., Wang, T., Chen, K., Zhu, W., & Wang, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132411 · Cited by 32
“Under physiological conditions, acute stimulation of FFAs could activate receptors in pancreatic β-cells, such as G-protein coupled receptor 40 (GPR40), to amplify insulin secretion pathway via increasing intracellular calcium concentration [4, 5].”
BackgroundImpaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
Ma, Y., Wang, Y., Huang, Q., Ren, Q., Chen, S., Zhang, A., Zhao, L., Zhen, Q., & Peng, Y. (2014) · Journal of Diabetes Research · doi:10.1155/2014/493039 · Cited by 31
Wu, P., Yang, L., & Shen, X. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.105 · Cited by 34
Dow, C., Mangin, M., Balkau, B., Affret, A., Boutron‐Ruault, M., Clavel‐Chapelon, F., Bonnet, F., & Fagherazzi, G. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516003883 · Cited by 36
“A few studies have also suggested that AA could stimulate insulin secretion((40,41)) and suggested that the plasma concentration of AA could be a key determinant of insulin resistance((42)).”
On, S., Kim, H. Y., Kim, H. S., Park, J., & Kang, K. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112625 · Cited by 31
“In fact, 10–20 μM DHA induces calcium influx in Chinese Hamster Ovary (CHO) cells expressing GPR40 [29].”
BackgroundLorza‐Gil, E., Kaiser, G., Ulven, E. R., König, G. M., Gerst, F., Oquendo, M. B., Birkenfeld, A. L., Häring, H., Kostenis, E., Ulven, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73467-5 · Cited by 32
The mechanisms linking adiposopathy to type 2 diabetes
Yang, J., Kang, J., & Guan, Y. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0288-9 · Cited by 33
“They demonstrated that FFAs regulated insulin secretion from pancreatic β cells through GPR40 [35].”
BackgroundThrombin stimulates insulin secretion via protease-activated receptor-3
Hänzelmann, S., Wang, J., Güney, E., Tang, Y., Zhang, E., Axelsson, A. S., Nenonen, H. A., Salehi, A. A., Wollheim, C. B., Zetterberg, E., et al. (2015) · Islets · doi:10.1080/19382014.2015.1118195 · Cited by 30
“glucagon-like peptide-1 receptor (GLP1R) and the free fatty acid receptor 1 (GPR40) as 2 examples.(7,8) However, we have still limited knowledge of how GPCRs affect the pathophysiology of T2D.”
BackgroundFree fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835
Krasavin, M., Lukin, A. Y., Bagnyukova, D., Zhurilo, N., Zahanich, I., Zozulya, S., Ihalainen, J. A., Forsberg, M., Lehtonen, M., Rautio, J., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.004 · Cited by 29
GPR40/FFAR1 deficient mice increase noradrenaline levels in the brain and exhibit abnormal behavior
Aizawa, F., Nishinaka, T., Yamashita, T., Nakamoto, K., Kurihara, T., Hirasawa, A., Kasuya, F., Miyata, A., & Tokuyama, S. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.09.007 · Cited by 34
Zhang, D., So, W. Y., Wang, Y., Wu, S. Y., Cheng, Q., & Leung, P. S. (2016) · Clinical Science · doi:10.1042/cs20160545 · Cited by 30
Kokotou, M. G., Mantzourani, C., Babaiti, R., & Kokotos, G. (2020) · Metabolites · doi:10.3390/metabo10010040 · Cited by 29
Decoding the Pyramid: A Systems‐Biological Approach to Nutrigenomics
Kaput, J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1323.011 · Cited by 30
Free Fatty Acids and Atherosclerosis—Guilty or Innocent?
Smith, S. R., & Wilson, P. W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1018 · Cited by 29
Hsu, Y.-C., & Ip, M. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.015 · Cited by 33
For Better or Worse: FFAR1 and FFAR4 Signaling in Cancer and Diabetes
Houthuijzen, J. M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105932 · Cited by 29
“FFAR1 is highly expressed in insulin-producing pancreatic b -cells and it has been shown to enhance glucose-induced insulin secretion leading to glucose uptake in cells (Itoh et al., 2003; Briscoe et al., 2006; Tomita et al., 2006).”
BackgroundFFA1‐selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models
Takeuchi, M., Hirasawa, A., Hara, T., Kimura, I., Hirano, T., Suzuki, T., Miyata, N., Awaji, T., Ishiguro, M., & Tsujimoto, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02052.x · Cited by 33
“The FFA1 receptor is a GPCR activated by medium- to long-chain fatty acids and expressed abundantly in pancreatic beta cells, where it mediates the FFA-enhanced, glucose-stimulated, secretion of insulin (Briscoe et al., 2003; Itoh et al., 2003; Poitout, 2003; Steneberg et al., 2005; Feng et al., 2006; Stoddart et al.,…”
BackgroundInfluentialTanaka, H., Yoshida, S., Oshima, H., Minoura, H., Negoro, K., Yamazaki, T., Sakuda, S., Iwasaki, F., Matsui, T., & Shibasaki, M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206466 · Cited by 31
“GPR40 is a free fatty acid (FFA) receptor and Gq-type, Gqcoupled G protein-coupled receptor that is highly expressed in pancreatic b-cells and whose stimulation by FFAs promotes insulin secretion (Briscoe et al., 2003; Itoh et al., 2003).”
BackgroundSelf-citationLópez, X., Cypess, A. M., Manning, R., O'Shea, S., Kulkarni, R., & Goldfine, A. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0627 · Cited by 30
Kwon, S., Wang, Y., Chen, J., Zhang, M.-Z., Harris, R. C., & Chen, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0113130 · Cited by 28
“Of note, GPR40 is most highly expressed in brain and pancreatic islets, leading to the suggestion that GPR40 is involved in the regulation of insulin secretion in response to free fatty acids [20,21].”
BackgroundZhang, Y., Xiao, M., Niu, G., & Tan, H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.047 · Cited by 30
Hirasawa, A., Itsubo, C., Sadakane, K., Hara, T., Shinagawa, S., Koga, H., Nose, H., Koshimizu, T., & Tsujimoto, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.142 · Cited by 32
Abaraviciene, S. M., Muhammed, S. J., Amisten, S., Lundquist, I., & Salehi, A. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.025 · Cited by 29
“Acute activation of b-cell GPR40 with various long-chain FFA was found to amplify glucosestimulated insulin release and challenged previous data suggesting that such an effect was mediated by the intracellular metabolism of FFA, generating various lipid-derived signals resulting in augmentation of the release process…”
InfluentialLiu, L., Wang, Z., Park, H. G., Xu, C., Lawrence, P., Su, X., Wijendran, V., Walker, W. A., Kothapalli, K. S. D., & Brenna, J. T. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.12.002 · Cited by 28
“Indeed, unbound FA mediated cellular signaling events are reversed by the addition of albumin [20, 21].”
BackgroundSparks, S. M., Aquino, C. J., Banker, P., Collins, J. L., Cowan, D. J., Diaz, C. J., Dock, S. T., Hertzog, D. L., Liang, X., Swiger, E., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.034 · Cited by 29
Lu, M. H., & Li, C. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13448 · Cited by 29
The Emerging Role of Promiscuous 7TM Receptors as Chemosensors for Food Intake
Wellendorph, P., Johansen, L. D., & Bräuner‐Osborne, H. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00005-9 · Cited by 36
Glucose-induced lipogenesis in pancreatic β-cells is dependent on SREBP-1
Sandberg, M. B., Fridriksson, J., Madsen, L., Rishi, V., Vinson, C., Holmsen, H., Berge, R. K., & Mandrup, S. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.05.005 · Cited by 31
Production et sécrétion de l'insuline par la cellule β pancréatique
Magnan, C., & Ktorza, A. (2005) · EMC - Endocrinologie · doi:10.1016/j.emcend.2005.07.001 · Cited by 76
Dietary lipids and sweeteners regulate glucagon-like peptide-2 secretion
Sato, S., Hokari, R., Kurihara, C., Sato, H., Narimatsu, K., Hozumi, H., Ueda, T., Higashiyama, M., Okada, Y., Watanabe, C., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00282.2012 · Cited by 27
“Both receptors are those for LCFFAs and found in the rat intestine (19, 24).”
BackgroundTakala, R., Ramji, D. P., & Choy, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021171 · Cited by 31
“It seems that co-activation of FFA1 enhances insulin production that is glucose-dependent [63,64], and FFA4 promotes insulin sensitivity and has anti-inflammatory effects [65,66].”
BackgroundShen, X., Yang, L., Yan, S., Wei, W., Liang, L., Zheng, H., & Cai, X. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.003 · Cited by 29
Sartorius, T., Drescher, A., Panse, M., Laštovička, P., Peter, A., Weigert, C., Kostenis, E., Ullrich, S., & Häring, H.-U. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374031 · Cited by 27
Ahangarpour, A., Zeidooni, L., Rezaei, M., Alboghobeish, S., Samimi, A., & Oroojan, A. A. (2017) · PubMed Central · doi:10.22038/ijbms.2017.9567 · Cited by 29
“study reported that the BA at dose of 10 μM do not make a significant change in islet insulin secretion (29);”
BackgroundMethodProm, C., Neto, J. M. D. S., Newbold, J. R., & Lock, A. L. (2021) · Journal of Dairy Science · doi:10.3168/jds.2021-20954 · Cited by 29
New Insights in the Control of Fat Homeostasis: The Role of Neurotensin
Barchetta, I., Baroni, M. G., Melander, O., & Cavallo, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042209 · Cited by 31
Silvestri, A., Gil‐Gómez, A., Vitale, M., Braga, D., Demitri, C., Brescia, P., Madaghiele, M., Spadoni, I., Jones, B., Fornasa, G., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101235 · Cited by 31
Fat Taste in Humans: Is It a Primary?
Mattes, R. D. (2010) · Cited by 28
The Therapeutic Potential of Allosteric Ligands for Free Fatty Acid Sensitive GPCRs
Hudson, B. D., Ulven, T., & Milligan, G. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313010004 · Cited by 27
“Another factor that has complicated the development of FFA1 as a therapeutic target is the fact that although shortterm fatty acid treatment enhances GSIS [75], chronic fatty acid exposure actually results in cell death and reduced insulin secretion [76].”
BackgroundInfluentialCvijanovic, N., Isaacs, N. J., Rayner, C. K., Feinle‐Bisset, C., Young, R. L., & Little, T. J. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.199 · Cited by 28
The Role and Future of FFA1 as a Therapeutic Target
Ghislain, J. J., & Poitout, V. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_51 · Cited by 31
“FFA1 is expressed in several regions of the central nervous system (CNS) in humans, primates, and rodents (Briscoe et al. 2003; Itoh et al. 2003; Nakamoto et al. 2012) and is increased following cerebral ischemia in neurogenic niches (Ma et al. 2008).”
BackgroundInfluentialLi, Z., Hu, L., Wang, X., Zhou, Z., Deng, L., Xu, Y., & Zhang, L. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103254 · Cited by 29
Souza, P. R., Walker, M. E., Goulding, N. J., Dalli, J., Perretti, M., & Norling, L. V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573019 · Cited by 29
Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT
Husted, A. S., Ekberg, J. H., Tripp, E., Nissen, T. A. D., Meijnikman, A. S., O’Brien, S. L., Ulven, T., Acherman, Y. I. Z., Bruin, S. C., Nieuwdorp, M., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101103 · Cited by 33
“Of these, FFAR1 is highly expressed in pancreatic and enteroendocrine cells [8,9], where it stimulates hormone secretion in response to dietary, triglyceride-derived LCFAs [10,11].”
BackgroundThimmarayappa, J., Sun, J., Schultz, L. E., Dejkhamron, P., Lü, C., Giallongo, A., Merchant, J. L., & Menon, R. K. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0128 · Cited by 27
“Whereas the observed effects of FA on GH receptor gene expression are restricted to medium-chain saturated FAs, GPR40 is activated by medium and long chain saturated and unsaturated FAs (28, 29), GPR41 and GPR43 by short chain carboxylic acids (30–32), 2754 Mol Endocrinol, November 2006, 20(11):2747–2760 Thimmarayappa…”
BackgroundInfluentialWagner, R. J., Staiger, H., Ullrich, S., Stefan, N., Fritsche, A., & Häring, H. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.001 · Cited by 27
“In 2003, when the role of a cell-membrane receptor, the orphan G-protein coupled receptor 40 (GPR40) was established [7], it was renamed free fatty acid receptor 1 (FFAR1) and is now considered as an important mediator of FFA-induced insulin secretion [3].”
BackgroundDiscontinued in 2013: diabetic drugs
Hedrington, M. S., & Davis, S. N. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.964859 · Cited by 26
“GPR40 is expressed in pancreatic b cells and it enhances glucose stimulated insulin release when activated by FFAs [33].”
BackgroundReardon, M. A., Gobern, S., Martinez, K., Shen, W., Reid, T., & McIntosh, M. (2012) · Lipids · doi:10.1007/s11745-012-3711-0 · Cited by 32
Nehra, D., Pan, A., Le, H. D., Fallon, E. M., Carlson, S. J., Kalish, B. T., & Puder, M. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.01.037 · Cited by 26
Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation
Heckel, É., Cagnone, G., Agnihotri, T., Cakir, B., Das, A., Kim, J. S., Kim, N., Lavoie, G., Situ, A., Pundir, S., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.154174 · Cited by 29
“FFAR1 was first discovered in the pancreas, where it regulates insulin secretion (24).”
BackgroundGuan, H.-P., & Xiong, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043828 · Cited by 30
“levels, which in turn causes glucose-dependent insulin secretion (Briscoe et al., 2003; Itoh et al., 2003).”
BackgroundHypothalamic free fatty acid receptor-1 regulates whole-body energy balance
Dragano, N. R. V., Milbank, E., Haddad-Tóvolli, R., Garrido‐Gil, P., Nóvoa, E., Fondevila, M. F., Capelli, V., Zanesco, A. M., Solon, C., Morari, J., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101840 · Cited by 26
“Originally, it was described as coupled with Gq protein, activating signal transduction through phospholipase C, and leading to increased intracellular levels of inositol trisphosphate and calcium (Ca 2 þ ) [2].”
BackgroundInfluentialMena, J., Manosalva, C., Ramirez, R., Chandia, L., Carroza, D., Loaiza, A., Burgos, R. A., & Hidalgo, M. A. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.11.017 · Cited by 28
Loss of Egr-1 sensitizes pancreatic β-cells to palmitate-induced ER stress and apoptosis
Cheong, M.-W., Kuo, L.-H., Cheng, Y.-N., Tsai, P.-J., Ho, L., Tai, H.-C., Chiu, W., Chen, S., Lu, P., Shan, Y.-S., et al. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1272-4 · Cited by 27
“Medium- and longchain saturated and unsaturated fatty acids (C12~18) increase calcium concentration, but short-chain fatty acids (C2~8) do not [21, 30].”
BackgroundInvolvement of the Long-Chain Fatty Acid Receptor GPR40 in Depression-Related Behavior
Nishinaka, T., Yamashita, T., Nakamoto, K., Kasuya, F., & Tokuyama, S. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14001sc · Cited by 30
3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists
Walsh, S. P., Severino, A., Zhou, C., He, J., Liang, G., Tan, C. P., Cao, J., Eiermann, G. J., Xu, L., Salituro, G., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.114 · Cited by 28
Puebla, C., Cisterna, B. A., Salas, D. P., Delgado‐López, F., Lampe, P. D., & Sáez, J. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.002 · Cited by 28
“Interestingly, the effects of LA, a ω-6 long chain FFA, have been associated with GPR40 [25, 45].”
InfluentialFukushima, K., Takahashi, K., Fukushima, N., Honoki, K., & Tsujiuchi, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.023 · Cited by 26
Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes
Liao, W., Lee, W., Chen, C., Lu, C. H., Chen, C.-H., Chou, Y., Lee, I., Sheu, W. H., Wu, J.-Y., Yang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14951 · Cited by 27
“Studies have demonstrated that agonists of G-proteincoupled receptor 40 (GPR40) and free fatty acid (FFA) receptor 1 (FFAR1) are induced by β-cell insulin secretion [38].”
BackgroundAhangarpour, A., Oroojan, A. A., Rezaei, M., Khodayar, M. J., Alboghobeish, S., & Zeinvand‐Lorestani, M. (2017) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v0i0.1014 · Cited by 26
Mule, N., Leon, A. C. O., Falck, J. R., Arand, M., & Marowsky, A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.013 · Cited by 26
Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors
Cooper, A. G., Singh, S., Hook, S. M., Tyndall, J. D. A., & Vernall, A. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013243 · Cited by 31
“FFA1 receptor, known at the time as GPR40, was identified in 2003 (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003) and is expressed in high levels in pancreatic b anda cells, monocytes, and various enteroendocrine and nervous system cells (reviewed inMancini and Poitout, 2013).”
BackgroundRives, M., Rady, B., Swanson, N., Zhao, S., Qi, J., Arnoult, É., Bakaj, I., Mancini, A. D., Breton, B., Lee, S. P., et al. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111369 · Cited by 27
“…b -cells and stimulates the release of incretins, such as glucagon-like peptide 1 (GLP-1), from enteroendocrine cells (Briscoe et al., 2003, 2006; Itoh et al., 2003; Yonezawa et al., 2004; Hardy et al., 2005; Shapiro et al., 2005; Tomita et al., 2005; Latour et al., 2007; Edfalk et al., 2008;…”
BackgroundGoverna, P., Caroleo, M. C., Carullo, G., Aiello, F., Cione, E., & Manetti, F. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127969 · Cited by 28
Doliba, N. M., Qin, W. D., Vinogradov, S. A., Wilson, D. F., & Matschinsky, F. M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00072.2010 · Cited by 27
“It is considered that fatty acids (FA) alter -cell function by two different mechanisms: by signaling through the FFA G proteincoupled receptor 40 (19) or by entering into intermediary metabolism of -cells, where they are either oxidized via the -oxidation pathway for energy production when the glucose level is low or…”
BackgroundYeung-Yam-Wah, V., Lee, A. K., Tse, F. W., & Tse, A. (2009) · Cell Calcium · doi:10.1016/j.ceca.2009.11.007 · Cited by 27
Free Fatty Acids and Free Fatty Acid Receptors: Role in Regulating Arterial Function
Yu, F., Zong, B., Ji, L., Sun, P., Jia, D., & Wang, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147853 · Cited by 28
“GPR40 is primarily distributed in VECs, nerves, pancreatic β -cells, enteroendocrine cells, and immune cells [18–20, 40, 128– 130].”
BackgroundHarada, S., Haruna, Y., Aizawa, F., Matsuura, W., Nakamoto, K., Yamashita, T., Kasuya, F., & Tokuyama, S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.036 · Cited by 29
“It has been reported that DHA has a relatively higher affinity for GPR40 than other fatty acids (Itoh et al., 2003).”
Lombardo, M., Bender, K., London, C., Plotkin, M. A., Kirkland, M. E., Mane, J., Pachanski, M. J., Geissler, W. M., Cummings, J. J., Habulihaz, B., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.10.054 · Cited by 25
de Souza, J., Prom, C., & Lock, A. L. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-19311 · Cited by 30
Plin5, a New Target in Diabetic Cardiomyopathy
Cui, X., Wang, J., Zhang, Y., Wei, J.-L., & Wang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2122856 · Cited by 27
PI3K and AKT at the Interface of Signaling and Metabolism
Solinas, G., & Becattini, B. (2022) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-06566-8_13 · Cited by 39
Kim, J.-M., Lee, K., Park, S., Kang, S., Huang, J., Lee, J.-M., Sato, K., Chung, H., Okajima, F., & Im, D. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.29 · Cited by 26
Therapeutic Role and Ligands of Medium- to Long-Chain Fatty Acid Receptors
Hara, T., Ichimura, A., & Hirasawa, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00083 · Cited by 29
“Among FFAR family, FFA1 (known as GPR40) and FFA4 (known as GPR120) are classified as medium- to long-chain fatty acid-activated receptors (4, 5).”
BackgroundInfluentialSynthesis and biological evaluation of GPR40/FFAR1 agonists containing 3,5-dimethylisoxazole
Yang, L., Zhang, J., Si, L., Han, L., Zhang, B., Ma, H., Xing, J., Zhao, L., Zhou, J., & Zhang, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.054 · Cited by 25
Molecular regulation of insulin granule biogenesis and exocytosis
Röder, P. V., Wong, X. M., Hong, W., & Han, W. (2016) · Biochemical Journal · doi:10.1042/bcj20160291 · Cited by 33
Mechanisms of beneficial effects of metformin on fatty acid-treated human islets
Cen, J., Sargsyan, E., Forslund, A. H., & Bergsten, P. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0304 · Cited by 28
Kapoor, G., Pathak, D. P., Bhutani, R., Husain, A., Jain, S., & Iqbal, M. A. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.12.004 · Cited by 25
Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer
Chu, X., Zhou, Q., Xu, Y.-C., Jiang, J., Li, Q., Zhou, Q., Wu, Q., Jin, M., Wang, H., Gu, Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1040-3 · Cited by 28
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.